+44 (0) 1223 755950
+1 832 327 7413
Orders to United States ship from United States
Target | Lymphokine-activated killer T-cell-originated protein kinase Phospho-Thr9 (PBK pT9) |
Clonality | Polyclonal |
Target Modification | Thr9 |
Modification | Phosphorylation |
Reactivity | Human |
Tested Applications | ELISA, WB, IHC |
Host | Rabbit |
Recommended dilutions | ELISA: 1/40000, WB: 1/500 - 1/2000, IHC: 1/100 - 1/300. Optimal dilutions/concentrations should be determined by the end user. |
Conjugation | Unconjugated |
Immunogen | Synthesized peptide derived from human PBK around the phosphorylation site of T9. |
Isotype | IgG |
Form | Liquid |
Purification | Purified by affinity chromatography. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
UniProt Primary AC | Q96KB5 (UniProt, ExPASy) |
UniProt Secondary AC | B4DX68, D3DST2, Q9NPD9, Q9NYL7, Q9NZK6 |
UniProt Entry Name | TOPK_HUMAN |
Gene Symbol | PBK |
GeneID | 55872 |
KEGG | hsa:55872 |
String | 9606.ENSP00000428489 |
Buffer | PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
Availability | Shipped within 5-10 working days. |
Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |